Interferon-gamma inhibits aldehyde dehydrogenase(bright) cancer stem cells in the 4T1 mouse model of breast cancer

BACKGROUND: Despite improvements in disease diagnosis, treatment, and prognosis, breast cancer is still a leading cause of cancer death for women. Compelling evidence suggests that targeting cancer stem cells (CSCs) have a crucial impact on overcoming the current shortcomings of chemotherapy and rad...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhuang, Xiufen, Shi, Guilan, Hu, Xiao, Wang, Huiru, Sun, Wen, Wu, Yanhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8769120/
https://www.ncbi.nlm.nih.gov/pubmed/34890380
http://dx.doi.org/10.1097/CM9.0000000000001558

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8769120/
https://www.ncbi.nlm.nih.gov/pubmed/34890380
http://dx.doi.org/10.1097/CM9.0000000000001558

Ejemplares similares